Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation
Pratik A. Patel(Emory University), Muna Qayed(Emory University), Kathryn Goggin(Children's Healthcare of Atlanta), Elizabeth Stenger(Emory University), Mehgan Teherani(The University of Texas Southwestern Medical Center), Preeti Jaggi(Emory University), Wayne H. Liang(Emory University), Shanmuganathan Chandrakasan(Emory University), Kirsten M. Williams(National Institutes of Health), Michelle Long Schoettler(Children's Healthcare of Atlanta), Kathleen Walsh Spencer(Children's Healthcare of Atlanta), Yijin Xiang(Emory University), Edwin M. Horwitz(St. Jude Children's Research Hospital), Valeria Bernardo(Children's Healthcare of Atlanta), Suhag Parikh(Emory University), Ann E. Haight, Benjamin Watkins(Emory University)
Cited by 5
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|247
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita
|Biology of Blood and Marrow Transplantation|2013|130
Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer
|JAMA Oncology|2019|130
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
|Transplantation and Cellular Therapy|2022|130